New Indian patent law could mean more attention to neglected diseases

01/5/2005 | Business Standard (India)

India's new patent law means hope for more innovation to produce drugs for treating neglected diseases, according to the head of an organization dedicated to the subject. India accounts for 1.8% of the world's estimated $406 billion pharmaceutical market, he said, but only 1% of India's production is for neglected diseases. With the new patent law, Indian drugmakers will have to develop new drugs and delivery systems, the executive director of the group said, adding that much of it should be centered on neglected diseases.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD